Development of DNA Ink & DNA Barcoding Technology on Practical Tracking & Authenticity Detection of Pharmaceutical Ingredients

Author :  

Year-Number: 2022-3
Yayımlanma Tarihi: 2022-12-21 13:15:54.0
Language : English
Konu : Molecular biology and genetics
Number of pages: 19-29
Mendeley EndNote Alıntı Yap

Abstract

Keywords

Abstract

Every year, millions of drugs are discarded by consumers before they expire, assuming they have deteriorated. We must recognize that this has negative consequences for our country and the world. Furthermore, when the World Health Organization data is examined, we can see that approximately 50% of the drugs are used incorrectly or unnecessarily, or they are thrown away without even opening the box, indicating that the waste is significant. It is expected that a DNA-based ink will be developed and used in drug packaging, and drug degradation will be easily tracked. As a groundbreaking project in the field of health, the DNAINK method aims to enable drug users to detect the deterioration of drugs over time. Because the text on the drug boxes will be written with DNA ink, the goal of DNAINK is to determine whether the products still maintain their stability effectively. With the DNAINK method and barcoding technology, it will be possible to determine whether a purchased drug is genuine or counterfeit, as well as whether the material deteriorates over time.

Keywords


  • Acar A, Yeğenoğlu S. Türkiye’de İlaçta Patent. Ankara Eczacılık Fakültesi Dergisi, 2004; 33(4) 269-85.

  • Açıkel CH. Akılcı İlaç Kullanımı. TAF Prev Med Bull. 2003; 1(11): 5-6.

  • Aji DY, İlter Ö. Türkiye’de Çocuk Zehirlenmeleri. Türk Pediatri Arşivi 1998; 33:154-158.

  • Akıcı, A. ve KALAÇA, S. (2013). “Topluma yönelik akılcı ilaçkullanımı”. Sosyal Güvenlik Kurumu Başkanlığı, SGK Yayın No: 93, Ankara

  • Ay, E. (2018), İlaç Sektöründe Lojistik Yönetimi ve TersineLojistik. Dönem Projesi, Sosyal Bilimler Enstitüsü, Pamukkale Üniversitesi.

  • Arnot DE, Roper C, Bayoumi RA. 1993. Digital codes fromhypervariable tandemly repeated DNA sequences in thePlasmodium falciparum circumsporozoite gene can geneticallybarcode isolates. Molecular and Biochemical Parasitology. 61:15- 24.

  • Aravind K, Ravikanth G, Shaanker RU, Chandrashekara K,Kumar ARV, Ganeshaiah KN. 2007. DNA barcoding: Anexercise in futility or utility? Current Science. 92(9):1213-1216.

  • Boğ, M. (2005). İlaç sektöründe lojistik uygulamalar (Doctoral dissertation, Fen Bilimleri Enstitüsü).

  • Busfield J. Assessing the overuse of medicines. Soc Sci Med. 2015;131:199–206.

  • Butler, N.J. The microbiological deterioration of cosmetics andpharmaceutical products. In Biodeterioration of Materials 269(1968) (Elsevier Publishing Co., Amsterdam, London and New York).

  • Centers for Disease Control and Prevention, (2003), “Guidelinesfor Maintaining and Managing The Vaccine Cold Chain”,Morbidity and Mortality Weekly Report,https://www.ncbi.nlm.nih.gov/pubmed/14574279 (Erişim Tarihi: 11.05.2020).

  • Chen X, Smith LM, Bradbury EM (March 2000). "Site-specificmass tagging with stable isotopes in proteins for accurate and efficient protein identification". Analytical Chemistry

  • European Environment Agency. Pharmaceuticals in theenvironment: results of an EEA Workshop. Copenhagen: EEA; 2010 (EEA Technical Report No 1/2010).

  • "Fluorescent labeling of biomolecules with organic probes - Presentations - PharmaXChange.info". 29 January 2011

  • Georgina,The structure of DNA,2019

  • Sürülmesinden Dolayı Devletin Sorumluluğu”, İlaç Hukuku,Editörler: Murat Şen/Ahmet Başözen, Erciyes ÜniversitesiHukuk Fakültesi I. Sağlık Hukuku Sempozyumu, 08-09 Mayıs 2009, Kayseri, 283.

  • Hertz, S. ve Alfredsson, M. (2003). Strategic development of thirdparty logistics providers. Industrial Marketing Management, 32(2), 139-149.

  • Holloway KA. Combating inappropriate use of medicines. Expert Rev Clin Pharmacol. 2011;4(3):335–48.

  • Hebert PDN, Gregory TR. 2005. The Promise of DNA Barcoding for Taxonomy. Systematic Biology. 54(5):852-859.

  • Hatchett,The medicines refrigerator and the importance of the cold chain in the safe storage of medicines,London,2017

  • İpekçi E. Tanyaş M. Soğuk Zincir Lojistiği Uygulamaları ve Türkiye’de Soğuk Zincir Lojistiğinin Swot Analizi, 2021.

  • Julian, Silvan, Kunal, Wendelin, Yaniv, A DNA-of-things storagearchitecture to create materials with embedded memory, Nature Biotechnology, 2020.

  • Johnson FH, Shimomura O, Saiga Y, Gershman LC, Reynolds GT, Waters JR. 1962. J. Cell. Comp. Physiol. 60:85–103

  • Kartoglu, Ümit ve Milstien, Julie (2014), Tools and Approachesto Ensure Quality of Vaccines throughout the Cold Chain, Expert Review of Vaccines, 13(7), s. 843-854.

  • Karakoç, H.D. (2005). İlaç Sektöründe Fiyat Rekabeti, Uzmanlık Tezi, Rekabet Kurumu, Ankara.

  • Le Grand, A., Hogerzeil, H. V., ve Haaijer-Ruskamp, F. M.(1999). “Intervention research in rational use of drugs: a review”. Health policy and planning, 14(2), 89-102.

  • Masaki, Development of Biometric DNA Ink for Authentication Security,PubMed, November 2004

  • Morin JG, Hastings JW. 1971. J. Cell. Physiol. 77:313–18

  • National Audit Office. Prescribing costs in primary care.London: National Audit Office; 2007 (www.nao.org.uk/ publications/0607/prescribing_costs_in_primary_c.aspx,

  • accessed 19 September 2016).

  • Physiol. 77:313–18 4. Morise H, Shimomura O, Johnson FH, Winant J. 1974. Biochemistry 13:2656– 62

  • Rajesh ,Richa,Ashok,Madhu, Molecular Mechanisms ofUltraviolet Radiation-Induced DNA Damage and Repair, 2010 Dec

  • Rajeshwar,Donat P, UV-induced DNA damage and repair: areview, 2002 Apr. Physiol. 77:313–18 4. Morise H, Shimomura O, Johnson FH, Winant J. 1974. Biochemistry 13:2656– 62

  • Shan,Zev, Rapid Short-Read Sequencing and AneuploidyDetection Using MinION Nanopore Technology, Genetics, Volume 202, Issue 1, 1 January 2016

  • Shimomura O, Johnson FH, Saiga Y. 1962. J. Cell. Comp. Physiol. 59:223– 39

  • Schneller, Smeltzer. Strategic Management of the Health Care Supply Chain (2006)

  • Thomas F, Depledge M. Medicine ‘misuse’: implications forhealth and environmental sustainability. Soc Sci Med. 2015;143:81–7

  • Timur, M. N. Tedarik zinciri-temel kavramlar. M. N. Timur & G.S. Çekerol (Edt.), Tedarik zinciri yönetimi içinde (s. 2-22).Eskişehir: Anadolu Üniversitesi Açıköğretim Fakültesi Yayınları. (2013)

  • Tengilimoğulu D. ve Yiğit V. (2013). Sağlık İşletmelerindeTedarik Zinciri ve Malzeme Yönetimi. Nobel Akademik Yayıncılık, İstanbul.

  • Yanxiao,Yuechuan,Cuifeng,Deqiang, Nanopore-based Fourth- generation DNA Sequencing Technology, February 2015

  • Walker, H. W. and Ayres, J. C. Yeasts as spoilage organisms. InThe Yeasts 3 463 (1969) (Academic Press, London and New YorkWen, Zhi - Liao Huchang - Ren Ruxue - Bai Chunguang -Zavadskas Edmundas Kazimieras - Antucheviciene Jurgita - Al-Barakati Abdullah, (2019), “Cold Chain Logistics Management ofMedicine with an Integrated Multi-Criteria Decision-MakingMethod”, International Journal of Environmental Research and Public Health, 16(23), 4843.

  • Nei M, Kumar S (2000). Molecular Evolution and Phylogenetics. 1st ed. New York, NY, USA: Oxford University Press.

                                                                                                                                                                                                        
  • Article Statistics